Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of ESBA1008 Versus LUCENTIS® for the Treatment of Exudative Age-Related Macular Degeneration

NCT01304693 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01304693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01304693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of ESBA1008 Versus LUCENTIS® for the Treatment of Exudative Age-Related Macular Degeneration
Lead sponsor
Alcon Research
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2010
Completion date
March 31, 2013
Enrollment
376 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration